The results of a previous study indicated that patients with a tumor size < 5 cm who are AFP negative are generally considered to have a better prognosis than patients with a tumor size > 5 cm who are AFP positive [26–29]; however, many of these patients still experience early disease recurrence and poor OS. This evidence concerns the gene AFP and neoplasm.